logo

For the Inventor, By the Inventor

Kawanishi, Japan

Kenzi Miyai

This inventor holds 12 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1984-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenzi Miyai. Retrieved from https://idiyas.com/inventor/kenzi-miyai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 236(Granted Patents)


Location History:

  • Hyogo, JP (1992)
  • Kawanishi, JP (1984 - 1997)

Company Filing History:

goldMedal12 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1984-1997

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5663163 - Cephem compounds and processes for preparation thereof (1997-09-02),
2. 5210080 - Cephem compounds (1993-05-11),
3. 5194432 - Cephem compounds (1993-03-16),
4. 5187160 - Cephem compound (1993-02-16),
5. 5162520 - Intermediates for cephem compounds (1992-11-10),
6. 5108997 - Cephem compounds (1992-04-28),
7. 4960766 - Cephem compounds (1990-10-02),
8. 4952578 - Cephem compound and a process for preparation thereof (1990-08-28),
9. 4927818 - Cephem compounds and processes for preparation thereof (1990-05-22),
10. 4761410 - Cephem Compounds (1988-08-02),
11. 4631274 - Halovinyl cephem compounds (1986-12-23),
12. 4487768 - Cephem compounds (1984-12-11),

Title: Kenzi Miyai: Innovator in Cephem Compounds

Introduction

Kenzi Miyai is a prominent inventor based in Kawanishi, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable advancements in the development of cephem compounds.

Latest Patents

Miyai's latest patents include innovative cephem compounds and processes for their preparation. One of his notable inventions relates to new cephem compounds, which are pharmaceutically acceptable salts and pharmaceutical compositions that exhibit anti-bacterial properties. These cephem compounds feature a thiadiazine ring bonded to the cephem through an iminoacetamido chain, along with a pyrazolium ring connected via a methylene chain. Additionally, he has developed cephem compounds that demonstrate antimicrobial activity, characterized by a specific chemical formula.

Career Highlights

Kenzi Miyai has established a successful career at Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's reputation but has also had a lasting impact on the pharmaceutical industry.

Collaborations

Miyai has collaborated with notable colleagues, including Kazuo Sakane and Takao Takaya, to further enhance the research and development of innovative pharmaceutical solutions.

Conclusion

Kenzi Miyai's contributions to the field of cephem compounds highlight his dedication to pharmaceutical innovation. His work continues to influence the development of effective antimicrobial treatments, showcasing the importance of research in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…